CREDIT SUISSE SECURITIES (USA) LLC
Eleven Madison Avenue
New York, New York 10010-3629
COWEN AND COMPANY, LLC
599 Lexington Avenue, 27th Floor
New York, New York 10022
VIA EDGAR
September 26, 2016
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, DC 20549-7010
Re: | Myokardia, Inc. |
Registration Statement on Form S-1
File No. 333-213680
Dear Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as the representatives of the several underwriters, hereby join in the request of MyoKardia, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 p.m. Eastern Time on September 27, 2016, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we, as the representatives of the several underwriters, expect to distribute approximately 200 copies of the Company’s preliminary prospectus, to be dated September 26, 2016, to underwriters, dealers, institutions and others.
We, the undersigned, as the representative of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
(signature page follows)
Very truly yours, | ||
CREDIT SUISSE SECURITIES (USA) LLC | ||
COWEN AND COMPANY, LLC | ||
As representative of the several underwriters | ||
By: CREDIT SUISSE SECURITIES (USA) LLC | ||
By: | /s/ Nathaniel Chang | |
Name: | Nathaniel Chang | |
Title: | Director | |
By: COWEN AND COMPANY, LLC | ||
By: | /s/ Grant Miller | |
Name: | Grant Miller | |
Title: | Managing Director, | |
Head of Equity Capital Markets |
(Signature Page to Acceleration Request Letter)